ClinicalTrials.gg
RecruitingNCT07424469Updated Oct 15, 2026

Foregut Leaks-Role of Microbiome

An interventional study of Biopsy and fluid samples in Gastrointestinal Diseases, sponsored by Baylor Research Institute. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Baylor Research Institute · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Aug 2020, registered Jun 2021).
  • Started Aug 2020; still recruiting 6 years 3 months later.
Updated Oct 15, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 200 studies in Gastrointestinal Diseases with a site in United States — 32 open to participants now, 42 under way, 5 of them phase 3. Gastrointestinal Diseases · United States.

Planned enrollment
87th of 141
50 · median 90
Started
2020
with 7 others
No phase
63 of 200
13 open now
Primary completion
2027-07
later than 19 of 41 live
Registered
145th of 200
by date

Among the 200 studies in Gastrointestinal Diseases with a site in United States, this one is the 87th largest by planned enrollment of the 141 interventional ones that give a count, is one of 8 that started in 2020, is one of 63 with no phase, reaches primary completion later than 19 of the 41 other live ones, and was the 145th registered.

Gastrointestinal Diseases

549 studies on the registry are indexed under Gastrointestinal Diseases; 102 are open to participants now.

Browse Gastrointestinal Diseases studies →

Open to participants now

32 of the 200 studies in Gastrointestinal Diseases with a site in United States are open now. Recruiting first, the newest first:

26 more — sign in →

All 32 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 66 Gastrointestinal Diseases studies recruiting now, 30 (45%) set no upper age limit and 23 (35%) stop at 75 or younger; 19 take children under 18; 21 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 200 studies in Gastrointestinal Diseases with a site in United States, or all of them as a file.
02

Study summary

Aims

  1. To understand the microbial composition involved with foregut leaks
  2. To define the virulence changes in the microbiota following foregut leaks
  3. To identify host response mechanisms and how they change with interventions
  4. Utilize this information to improve patient outcomes
Read the detailed description

For this study, investigators will compare the microbial composition of the infected fluid from the leak to that of a tissue sample taken from the participant. This will allow investigators to compare the composition and virulence of the microbiome both within and between participants. These comparisons will help further the understanding of the pathogenesis of these leaks, as well as identify which participants may be most at risk of developing postoperative leaks. The combination of this information has the potential to contribute to the development of preventative measures and improve patient outcomes.

03

Conditions studied

  • Gastrointestinal Diseases
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with an esophageal or stomach leak
  • Over 18 years old

Exclusion criteria

Exclusion Criteria:

  • Patients determined by physician/surgeon as not able to tolerate
  • Under 18 years old
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Other
    Sample collection

    Samples of microbial fluid and host biopsy taken

    Other: Biopsy and fluid samples

Interventions

  • OtherBiopsy and fluid samples

    Biopsy and fluid samples taken during other medically necessary procedure

06

What researchers measure

Primary outcomes

  1. Microbial composition of samples

    change in virulence factors, microbial response to treatment modalities

    Time frame: During the surgery

  2. Time of healing of leaks

    Time from index intervention to confirmed leaked closure as determined by imaging or endoscopic evaluation.

    Time frame: From index intervention until documented leak resolution ( up to 24 weeks)

  3. Proportion of patients achieving leak closure without need for additional surgical intervention

    Successful endoscopic management will be defined as complete leak resolution without requirement for subsequent operative surgical repair. This will be measured as a percentage of participants.

    Time frame: Up to 24 weeks post-surgery

  4. Incidence of postoperative complications

    Complications occurring within 30 days of surgery will be recorded. Percentage of participants with complications will be recorded.

    Time frame: Within 30 days post-surgery

Secondary outcomes

  1. Patient demographics

    age, sex, race, ethnicity

    Time frame: Baseline or anytime before surgery

  2. Patient risk of postoperative complications

    Calculated by ACS risk calculator

    Time frame: Post surgery until the time leak is healed ( up to 24 weeks)

07

Study locations

1 of 1 sites recruiting
  • Baylor Scott & White Center for Advanced Surgery
    Dallas, Texas 75246, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2020 (actual). Primary completion is estimated for Jul 2027, 82 months after the start.

Of 127 non-industry interventional studies with no phase under Gastrointestinal Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 82 months is above that.

Counting every sponsor, half of 149 studies reached it within 24 months; a quarter within 10 and three quarters within 45.

Primary completion moved once since we started tracking on Sep 25, 2026: Jul 2026 → Jul 2027, on Oct 15, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2021
First posted
Feb 20, 2026
StartActual
Aug 14, 2020
Primary completionEst.
Jul 1, 2027was Jul 2026
CompletionEst.
Jun 1, 2028
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 1, 2026→Jul 1, 2027
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Primary completion Jul 1, 2026→Jul 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07424469
Responsible party
Sponsor
First posted
Feb 20, 2026
Start date
Aug 14, 2020
Primary completion
Jul 1, 2027 (estimated)
Completion
Jun 1, 2028 (estimated)
Last update
Oct 15, 2026

Study contacts

Rehma Shabbir
Contact
Rehma.Shabbir@BSWHealth.org
2148201722

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion